TuHURA Biosciences announced it will present three posters at the 68th American Society of Hematology Annual Meeting in December 2026, highlighting the Delta Opioid Receptor (DOR) as a key regulator of immune suppressing cells involved in cancer and autoimmune diseases. Their research focuses on how DOR controls Myeloid-Derived Suppressor Cells (MDSCs), T regs, and M2 macrophages, which contribute to resistance against cancer immunotherapy. This work supports TuHURA's development of novel immune-modulating therapies, including antibody drug conjugates targeting these cells to improve cancer treatment outcomes. The presentations underscore the potential of DOR technology in creating new therapeutic options to overcome immunotherapy resistance.
TuHURA Biosciences' upcoming presentations at the American Society of Hematology Annual Meeting provide context for readers interested in health sector developments. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: out of 150 priced US health stocks, 127 rose and 19 fell. Notable movers include Novo Nordisk A/S (NVO) at USD 42.40 with a 5.50% increase and 90% buy order activity, Amgen, Inc. (AMGN) at USD 486.50 up 5.47%, and Heron Therapeutics Inc (HRTX) at USD 0.30 up 5.37%.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
